About Sandoz

Sandoz is a global leader in generic pharmaceuticals and biosimilars and a division of the Novartis Group. Our mission is to discover new ways to improve and extend people’s lives. Sandoz contributes to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. That is our purpose.

We are the pioneer and global leader in biosimilars with over a decade of experience. We invest in research and development to improve the lives of patients and liberate healthcare resources through increased access to high-quality, affordable biologics.

Learn more about biosimilars on Sandoz.com:

Sandoz biosimilars

Sandoz biosimilar pipeline

Development of biosimilars

Manufacturing of biosimilars

Talking about biosimilars with your patients

About Novartis

Sandoz is a division of Novartis. To learn more about Novartis, go to: https://www.novartis.com

Novartis produces Cosentyx®. To find out more about Cosentyx®, go to: https://www.cosentyx.com

Latest news about biosimilars

We use cookies to enhance your navigation through this website. To read more about cookies and how to change your browser settings, please click the following link. By clicking on the "Accept" button, we understand that you accept our Cookie Policy.